GROWTH EQUITY OPPORTUNITIES FUND IV, LLC --- ARCA BIOPHARMA, INC. - SCHEDULE 13D

Company

Oruka Therapeutics, Inc.

Filed

March 5, 2018

Accession Number

0001072613-18-000184